‘Quiet Giant’ Biocon Sets Out Vision For Biosimilars

Advanced Markets Chief Matt Erick Discusses Upcoming Milestones For Biocon Biologics

 
• By Dave Wallace
  
Matt Erick, Biocon Biologics
Matt Erick discusses the strategic priorities for Biocon Biologics • Source: Biocon

More from Biosimilars

More from Leadership